You need to rethink this. The only reasonable indication for Recell use is in conjunction with wider meshed skin grafts, which aren't that common except where large amount of skin is missing and donor areas are insufficient . It's only indirectly related to the use of Novosorb.
ReCell Go Is Massive, page-84
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.17 |
Change
0.180(6.02%) |
Mkt cap ! $223.2M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.18 | $3.12 | $1.124M | 356.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 410 | $3.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.17 | 2434 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |